Vapor Inhaler Inhalant
NDC Package 41163-031-01
Package Information
Vapor Inhaler (levmetamfetamine) inhalants is the product delivers in each 800 mL of air 0.04 to 0.150 mg of levmetamfetamine do not use more often than every 2 hours adults and children 12 years of age and over 2 inhalations in each nostril children 6 to under 12 years of age (with adult supervision) 1 inhalation in each nostril children under 6 years of age ask a doctor children under 2 years of age do not use. This formulation utilizes a inhalant delivery system. Marketed by Supervalu Inc., this product is identified by NDC 41163-031 and is authorized under FDA application M012.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 41163 - Supervalu Inc.
- 41163-031 - Vapor Inhaler
- 41163-031-01 - 1 INHALER in 1 BLISTER PACK / 198 INHALANT in 1 INHALER
- 41163-031 - Vapor Inhaler
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 41163-031-01 identifies a specific commercial package of 1 inhaler in 1 blister pack / 198 inhalant in 1 inhaler of Vapor Inhaler Levmetamfetamine Nasal Decongestant, Equaline, a human over the counter drug labeled by Supervalu Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This inhalant is formulated for nasal use and contains levmetamfetamine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Supervalu Inc. on February 24, 2021. The current certification is valid through December 31, 2026.
How is this Supervalu Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 41163003101. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.